Literature DB >> 28573163

Non-radioactive in vitro PINK1 Kinase Assays Using Ubiquitin or Parkin as Substrate.

Fabienne C Fiesel1,2, Roman Hudec1, Wolfdieter Springer1,2.   

Abstract

This protocol describes the in vitro phosphorylation of ubiquitin and Parkin by the kinase PINK1 using recombinant proteins. Both substrates, ubiquitin and Parkin, are phosphorylated at the conserved serine 65 residue (pS65-ubiquitin and pS65-Parkin). The protocol also includes the use of monomeric and K48- and K63-linked poly-ubiquitin chains as alternative substrates. Although there are commercially available antibodies, we have not tested their performance in this assay since, but used validated antibodies from our laboratory. An alternative antibody-independent method, the use of phostag gels to detect pS65-ubiquitin and pS65-Parkin, is described in addition.

Entities:  

Year:  2016        PMID: 28573163      PMCID: PMC5448420          DOI: 10.21769/BioProtoc.1946

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  2 in total

1.  Disease relevance of phosphorylated ubiquitin (p-S65-Ub).

Authors:  Fabienne C Fiesel; Wolfdieter Springer
Journal:  Autophagy       Date:  2015-11-02       Impact factor: 16.016

2.  (Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation.

Authors:  Fabienne C Fiesel; Maya Ando; Roman Hudec; Anneliese R Hill; Monica Castanedes-Casey; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Jeannette N Stankowski; Peter O Bauer; Oswaldo Lorenzo-Betancor; Isidre Ferrer; José M Arbelo; Joanna Siuda; Li Chen; Valina L Dawson; Ted M Dawson; Zbigniew K Wszolek; Owen A Ross; Dennis W Dickson; Wolfdieter Springer
Journal:  EMBO Rep       Date:  2015-07-10       Impact factor: 8.807

  2 in total
  3 in total

1.  MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.

Authors:  Agostinho G Rocha; Antonietta Franco; Andrzej M Krezel; Jeanne M Rumsey; Justin M Alberti; William C Knight; Nikolaos Biris; Emmanouil Zacharioudakis; James W Janetka; Robert H Baloh; Richard N Kitsis; Daria Mochly-Rosen; R Reid Townsend; Evripidis Gavathiotis; Gerald W Dorn
Journal:  Science       Date:  2018-04-20       Impact factor: 47.728

Review 2.  Mechanisms and roles of mitophagy in neurodegenerative diseases.

Authors:  Yan Wang; Na Liu; Bingwei Lu
Journal:  CNS Neurosci Ther       Date:  2019-05-02       Impact factor: 5.243

3.  Transcription- and phosphorylation-dependent control of a functional interplay between XBP1s and PINK1 governs mitophagy and potentially impacts Parkinson disease pathophysiology.

Authors:  Wejdane El Manaa; Eric Duplan; Thomas Goiran; Inger Lauritzen; Loan Vaillant Beuchot; Sandra Lacas-Gervais; Vanessa Alexandra Morais; Han You; Ling Qi; Mario Salazar; Umut Ozcan; Mounia Chami; Frédéric Checler; Cristine Alves da Costa
Journal:  Autophagy       Date:  2021-05-24       Impact factor: 16.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.